{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:55:12Z","timestamp":1793778912612,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031365","name":"Oslo universitetssykehus HF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004824","name":"Dansk Nefrologisk Selskab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004046","name":"Karen Elise Jensen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ajt.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:34:14Z","timestamp":1784356454000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epstein-Barr virus infection monitoring in kidney transplant recipients (EVITA study)\u2014investigating the clinical significance of EBV-DNAemia and the risk of early-onset PTLD"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9972-6249","authenticated-orcid":false,"given":"Lene Ugilt Pagter","family":"Ludvigsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Kragh","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grete Birkeland","family":"Kro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune Micha","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Maria","family":"Gramkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Kristina","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Charlotte","family":"Thiesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Midtvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ivarsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Jensen-Fangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Martin","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hamilton-Dutoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D\u2019Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Varberg","family":"Reis\u00e6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajt.2026.07.012_bib1","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study","volume":"71","author":"Van Delden","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.012_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/ajt.16106","article-title":"Characterizing the landscape and impact of infections following kidney transplantation","volume":"21","author":"Jackson","year":"2021","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.012_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofac243","article-title":"Incidences of infectious events in a renal transplant cohort of the German Center of Infectious Diseases (DZIF)","volume":"9","author":"Sommerer","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.ajt.2026.07.012_bib4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/tri.13734","article-title":"Relative and absolute cancer risks among Nordic kidney transplant recipients\u2014a population-based study","volume":"33","author":"Benoni","year":"2020","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.012_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/ejh.13815","article-title":"Early- and late-onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients","volume":"109","author":"Abdulovski","year":"2022","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.012_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14763","article-title":"Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: a prospective multicenter study in the United States","volume":"28","author":"Tajima","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.012_bib7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajt.2024.02.028","article-title":"The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch","volume":"24","author":"Attieh","year":"2024","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.012_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ajt.2025.01.035","article-title":"Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus\u2013seronegative kidney transplant recipients \u2014 an observational cohort study from Norway and western Denmark","volume":"25","author":"Ludvigsen","year":"2025","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.012_bib9","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/ajt.16423","article-title":"Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): a nationwide cohort study","volume":"21","author":"Walti","year":"2021","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.012_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13000","article-title":"Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients","volume":"31","author":"Kumar","year":"2017","journal-title":"Clin Transplant"},{"issue":"suppl 7","key":"10.1016\/j.ajt.2026.07.012_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1469-0691.12534","article-title":"Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients","volume":"20","author":"San-Juan","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajt.2026.07.012_bib12","article-title":"The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III \u2013 Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring","volume":"27","author":"Preiksaitis","year":"2023","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.012_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.012_bib14","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1111\/tid.13731","article-title":"The impact of chronic Epstein\u2013Barr virus infection on the liver graft of pediatric liver transplant recipients: a retrospective observational study","volume":"23","author":"Shizuku","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ajt.2026.07.012_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105579","article-title":"A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood","volume":"167","author":"Ludvigsen","year":"2023","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ajt.2026.07.012_bib16","article-title":"Collaborative Study to Evaluate the Proposed 1st WHO International Standard for Epstein-Barr Virus (EBV) for Nucleic Acid Amplification Technology (NAT)-Based Assays","author":"Fryer","year":"2011","journal-title":"WHO\/BS\/201"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.012_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13719","article-title":"Dynamics of Epstein\u2013Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant","volume":"23","author":"Lindsay","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.012_bib18","doi-asserted-by":"crossref","DOI":"10.1590\/2175-8239-jbn-2024-0040en","article-title":"Age and Epstein-Barr viral load at diagnosis of post-transplant lymphoproliferative disease are associated with patient survival in kidney transplant recipients","volume":"46","author":"Francisco","year":"2024","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.ajt.2026.07.012_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105758","article-title":"Limited utility of Epstein\u2013Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients","volume":"176","author":"Mah","year":"2025","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ajt.2026.07.012_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13730","article-title":"A multicenter survey on post-transplant lymphoproliferative disorders in pediatric heart transplant recipients: A case for development of consensus guidelines for screening, surveillance, and treatment?","volume":"24","author":"Weisert","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.012_bib21","doi-asserted-by":"crossref","first-page":"604.e1","DOI":"10.1016\/j.cmi.2015.02.002","article-title":"Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey","volume":"21","author":"San-Juan","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.012_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/ajt.12009","article-title":"Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: Incidence and consequences","volume":"13","author":"Bamoulid","year":"2013","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2026.07.012_bib23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0000000000001280","article-title":"Late persistent positive EBV viral load & risk of solid cancer in kidney transplant patients","volume":"101","author":"Bamoulid","year":"2017","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.012_bib24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/TP.0b013e31827a4bd6","article-title":"Epstein-Barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients","volume":"95","author":"San-Juan","year":"2013","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.012_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy050","article-title":"Quantification of Torque teno virus and Epstein-Barr virus is of limited value for predicting the net state of immunosuppression after lung transplantation","volume":"5","author":"Nord\u00e9n","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"25","key":"10.1016\/j.ajt.2026.07.012_bib26","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajt.2026.07.012_bib27","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/ndt\/gfl131","article-title":"Steroid-free immunosuppression after renal transplantation: Long-term experience from a single centre","volume":"21","author":"El-Faramawi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.012_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/petr.12186","article-title":"Long-term experience of steroid-free pediatric renal transplantation: effects on graft function, body mass index, and longitudinal growth","volume":"18","author":"Wittenhagen","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ajt.2026.07.012_bib29","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.012_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1016\/j.ajt.2026.07.012_bib31","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.012_bib32","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1016\/j.ajt.2026.07.012_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00267-24","article-title":"Performance of the cobas EBV and cobas BKV assays: multi-site comparison of standardized quantitation","volume":"62","author":"Mannonen","year":"2024","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.012_bib34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/tri.12744","article-title":"Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study","volume":"29","author":"Maksten","year":"2016","journal-title":"Transpl Int."},{"issue":"2","key":"10.1016\/j.ajt.2026.07.012_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/ANNALS-24-00165","article-title":"The association of Epstein-Barr virus donor and recipient serostatus with outcomes after kidney transplantation: a retrospective cohort study","volume":"178","author":"Potluri","year":"2025","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.012_bib36","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00432-018-2674-9","article-title":"The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients","volume":"144","author":"Wareham","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ajt.2026.07.012_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cis823","article-title":"Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study","volume":"56","author":"H\u00f6cker","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ajt.2026.07.012_bib38","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00467-017-3627-2","article-title":"Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients","volume":"32","author":"Colombini","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.ajt.2026.07.012_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1309\/AJCP9WYEXKOL9YUV","article-title":"Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having post-transplant lymphoproliferative disorders","volume":"141","author":"Cho","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.ajt.2026.07.012_bib40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1399-0012.2012.01608.x","article-title":"Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder","volume":"26","author":"Holman","year":"2012","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2026.07.012_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.ajt.2026.07.012_bib42","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/tri.13982","article-title":"Risk factors for Epstein\u2013Barr virus reactivation after renal transplantation: results of a large, multi-centre study","volume":"34","author":"Blazquez-Navarro","year":"2021","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.ajt.2026.07.012_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00467-019-04401-9","article-title":"Long-lasting chronic high load carriage of Epstein-Barr virus is more common in young pediatric renal transplant recipients","volume":"35","author":"Ladfors","year":"2020","journal-title":"Pediatr Nephrol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526026729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613526026729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:27:26Z","timestamp":1786879646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613526026729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S1600613526026729"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.012","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus infection monitoring in kidney transplant recipients (EVITA study)\u2014investigating the clinical significance of EBV-DNAemia and the risk of early-onset PTLD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}